DOCGO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.61 USD | +3.44% |
|
+1.12% | -35.42% |
| Sales 2024 * | 725M 58.05B | Sales 2025 * | 735M 58.83B | Capitalization | 368M 29.49B |
|---|---|---|---|---|---|
| Net income 2024 * | 34M 2.72B | Net income 2025 * | 42M 3.36B | EV / Sales 2024 * | 0.35 x |
| Net cash position 2024 * | 113M 9.02B | Net cash position 2025 * | 170M 13.6B | EV / Sales 2025 * | 0.27 x |
| P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
9.13
x | Employees | 3,540 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.51% |
More Fundamentals
* Assessed data
More news
Latest transcript on DocGo Inc.
More recommendations
More press releases
| 1 day | +3.44% | ||
| 1 week | +1.12% | ||
| Current month | -10.64% | ||
| 1 month | -11.08% | ||
| 3 months | +1.98% | ||
| 6 months | -39.93% | ||
| Current year | -35.42% |
1 week
3.33
3.66
1 month
2.844.07
Current year
2.785.61
1 year
2.7810.82
3 years
2.7811.86
5 years
2.7811.86
10 years
2.7811.86
| Managers | Title | Age | Since |
|---|---|---|---|
Bienstock Lee
CEO | Chief Executive Officer | 40 | 27/03/22 |
Norman Rosenberg
DFI | Director of Finance/CFO | 54 | 30/12/22 |
Stephen Sugrue
CMP | Compliance Officer | 52 | 31/12/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ely D. Tendler
BRD | Director/Board Member | 56 | 31/12/14 |
James Travers
BRD | Director/Board Member | 71 | 04/11/21 |
Michael Burdiek
BRD | Director/Board Member | 64 | 04/11/21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 237 M€ | +2.89% | - | |
| 0.02% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 3.61 | +3.44% | 467,832 |
| 25/04/24 | 3.49 | -0.85% | 688,679 |
| 24/04/24 | 3.52 | +0.57% | 465,329 |
| 23/04/24 | 3.5 | -0.28% | 570,366 |
| 22/04/24 | 3.51 | -1.68% | 959,650 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotes
DocGo Inc. is a healthcare transportation and mobile services company. The Company uses dispatch and communication technology to help provide healthcare transportation and mobile services in-person medical treatment directly to patients in the comfort of their homes, workplaces, and other non-traditional locations, in metropolitan cities in the United States and the United Kingdom. Its segments include Mobile Health Services, Transportation Services and Corporate. Mobile Health Services include a wide variety of healthcare services performed at homes, offices and other locations and event services such as on-site healthcare support at sporting events and concerts. Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports. Corporate segment represents shared services and personnel that support both the Transportation Services and Mobile Health Services segments.
Calendar
08/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
13.26
AED
Average target price
36.31
AED
Spread / Average Target
+173.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -35.42% | 368M | |
| -3.44% | 3B | |
| 0.00% | 1.81B | |
| +49.28% | 624M | |
| -3.09% | 503M | |
| -34.25% | 139M | |
| -13.04% | 136M | |
| +1.92% | 67.7M |
- Stock Market
- Equities
- DCGO Stock
